This company has been marked as potentially delisted and may not be actively trading.

Acxiom (ACXM) Financials

Annual Income Statements for Acxiom

This table shows Acxiom's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015	3/31/2014
Net Income / (Loss) Attributable to Common Shareholders	12	-119	-34	-90	-125	1,029	23	4.11	6.70	-11	8.86
Consolidated Net Income / (Loss)	12	-119	-34	-90	-125	1,029	23	4.11	6.70	-11	8.80
Net Income / (Loss) Continuing Operations	10	-124	-34	-90	-125	-134	-67	-86	-8.65	-27	-17
Total Pre-Tax Income	34	-119	-35	-121	-166	-179	-133	-131	-20	-41	-5.30
Total Operating Income	11	-126	-66	-121	-181	-198	-134	-131	-13	-33	1.56
Total Gross Profit	480	426	381	299	228	165	124	75	362	311	300
Total Revenue	660	597	529	443	381	286	220	175	850	805	805
Operating Revenue	660	597	529	443	381	286	220	175	850	805	805
Total Cost of Revenue	179	170	147	144	153	121	96	100	488	494	506
Operating Cost of Revenue	179	170	147	144	153	121	96	100	488	494	506
Total Operating Expenses	469	552	447	420	409	363	257	206	375	344	298
Selling, General & Admin Expense	110	125	105	104	109	99	88	98	148	153	117
Marketing Expense	196	202	183	178	189	159	109	59	146	116	94
Research & Development Expense	151	189	158	135	106	86	61	49	74	74	63
Other Operating Expenses / (Income)	12	35	1.48	2.72	5.00	20	-	-	-	-	-
Total Other Income / (Expense), net	23	6.95	30	-0.25	15	19	0.50	0.65	-7.22	-8.66	-6.86
Income Tax Expense	24	5.25	-1.24	-31	-40	-45	-66	-45	-12	-15	12
Net Income / (Loss) Discontinued Operations	1.79	5.40	0.00	0.00	0.75	1,162	91	90	15	16	26
Basic Earnings per Share	$0.18	($1.79)	($0.50)	($1.36)	($1.84)	$13.71	$0.30	$0.05	$0.09	($0.14)	$0.12
Weighted Average Basic Shares Outstanding	66.15M	66.40M	68.41M	68.41M	65.34M	75M	78.89M	82.20M	77.62M	77.11M	74.69M
Diluted Earnings per Share	$0.17	($1.79)	($0.50)	($1.36)	($1.84)	$13.71	$0.30	$0.05	$0.09	($0.14)	$0.12
Weighted Average Diluted Shares Outstanding	66.15M	66.40M	68.41M	68.41M	65.34M	75M	78.89M	82.20M	77.62M	77.11M	74.69M
Weighted Average Basic & Diluted Shares Outstanding	66.15M	66.40M	68.41M	68.41M	65.34M	75M	78.89M	82.20M	77.62M	77.11M	74.69M

This table shows Acxiom's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Income / (Loss) Attributable to Common Shareholders	11	1.73	-7.49	-5.37	14	4.86	-1.59	-31	-30	-30	-27
Consolidated Net Income / (Loss)	11	1.73	-7.49	-5.37	14	4.86	-1.59	-31	-30	-30	-27
Net Income / (Loss) Continuing Operations	9.52	1.73	-7.49	-6.18	13	4.48	-1.59	-36	-31	-30	-27
Total Pre-Tax Income	19	12	-0.80	-9.21	22	15	7.12	-42	-25	-27	-25
Total Operating Income	15	7.49	-5.25	-14	15	8.21	2.27	-47	-24	-29	-26
Total Gross Profit	140	134	124	124	129	119	108	105	115	105	101
Total Revenue	195	185	176	172	174	160	154	149	159	147	142
Operating Revenue	195	185	176	172	174	160	154	149	159	147	142
Total Cost of Revenue	55	51	52	48	45	41	46	43	43	42	41
Operating Cost of Revenue	55	51	52	48	45	41	46	43	43	42	41
Total Operating Expenses	126	127	129	138	114	110	106	152	139	134	127
Selling, General & Admin Expense	32	31	31	30	27	26	27	33	37	29	27
Marketing Expense	51	51	54	60	46	44	45	58	48	46	51
Research & Development Expense	43	44	44	45	38	34	35	52	43	46	48
Other Operating Expenses / (Income)	0.15	0.40	0.21	2.52	2.50	6.57	0.12	9.72	12	13	0.74
Total Other Income / (Expense), net	4.03	4.20	4.44	5.07	6.61	6.43	4.85	4.74	-0.74	2.25	0.70
Income Tax Expense	9.18	9.95	6.69	-3.03	8.43	10	8.71	-6.46	5.84	3.56	2.32
Net Income / (Loss) Discontinued Operations	1.69	0.00	-	-	0.60	0.39	-	-	0.84	0.00	-
Basic Earnings per Share	$0.17	$0.03	($0.11)	($0.08)	$0.21	$0.07	($0.02)	($0.48)	($0.46)	($0.45)	($0.40)
Weighted Average Basic Shares Outstanding	65.76M	65.26M	66.61M	66.15M	66.18M	65.51M	66.19M	66.40M	64.71M	66.48M	67.14M
Diluted Earnings per Share	$0.17	$0.03	($0.11)	($0.09)	$0.21	$0.07	($0.02)	($0.48)	($0.46)	($0.45)	($0.40)
Weighted Average Diluted Shares Outstanding	65.76M	65.26M	66.61M	66.15M	66.18M	65.51M	66.19M	66.40M	64.71M	66.48M	67.14M
Weighted Average Basic & Diluted Shares Outstanding	65.76M	65.26M	66.61M	66.15M	66.18M	65.51M	66.19M	66.40M	64.71M	66.48M	67.14M

This table details how cash moves in and out of Acxiom's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015	3/31/2014
Net Change in Cash & Equivalents	-125	-136	18	-152	-329	921	-30	-20	49	-278	196
Net Cash From Operating Activities	106	34	78	-21	-29	-1.98	-14	-26	114	61	96
Net Cash From Continuing Operating Activities	106	34	78	-21	-29	-1.98	-14	-26	114	61	96
Net Income / (Loss) Continuing Operations	10	-124	-34	-90	-125	-134	-67	-86	-8.65	-27	-17
Consolidated Net Income / (Loss)	12	-119	-34	-90	-125	1,029	23	4.11	6.70	-11	8.80
Net Income / (Loss) Discontinued Operations	1.79	5.40	0.00	0.00	0.75	1,162	91	90	15	16	26
Depreciation Expense	12	21	24	28	36	34	38	32	85	80	57
Non-Cash Adjustments To Reconcile Net Income	79	159	60	115	91	109	58	42	39	25	36
Changes in Operating Assets and Liabilities, net	5.09	-15	36	-73	-25	-11	-42	-15	-1.70	-18	20
Net Cash From Investing Activities	-174	-29	7.58	-88	-116	-11	-14	-124	-69	-343	-55
Net Cash From Continuing Investing Activities	-174	-29	7.58	-88	-116	-11	-14	-124	-69	-343	-55
Purchase of Property, Plant & Equipment	-4.26	-4.70	-4.50	-2.18	-12	-8.64	-13	-28	-64	-77	-58
Acquisitions	-171	-0.50	-19	-78	-105	-2.50	-5.48	-138	-5.39	-266	-0.50
Purchase of Investments	-49	-28	0.00	-7.50	0.00	0.00	-	-	-	-	-
Sale and/or Maturity of Investments	51	4.39	0.00	0.00	-	-	-	-	-	-	3.82
Other Investing Activities, net	0.00	0.00	31	0.00	0.00	-	-	-	-	-	-
Net Cash From Financing Activities	-59	-146	-67	-43	-202	-842	-82	26	-126	-27	103
Net Cash From Continuing Financing Activities	-59	-146	-67	-43	-202	-842	-82	26	-126	-27	103
Repurchase of Common Equity	-61	-150	-59	-42	-182	-74	-89	-31	-53	-9.87	-53
Issuance of Common Equity	7.22	6.26	6.27	8.74	4.74	20	20	21	10	5.04	80
Other Financing Activities, net	-5.84	-2.27	-15	-9.92	-25	-554	-11	-2.57	3.55	4.65	11
Effect of Exchange Rate Changes	0.37	-	-	-	-	-1.75	-	-1.57	-0.38	-1.62	0.62
Other Net Changes in Cash	1.79	4.85	-0.20	0.00	18	1,778	80	106	131	33	51
Cash Income Taxes Paid	2.47	5.80	-33	-2.91	-7.34	440	-1.24	-6.87	6.10	-3.85	22

This table details how cash moves in and out of Acxiom's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Net Change in Cash & Equivalents	36	29	-26	-159	6.78	21	6.33	11	-32	-23	-92
Net Cash From Operating Activities	45	56	-9.33	28	17	36	26	31	16	21	-33
Net Cash From Continuing Operating Activities	45	56	-9.33	28	17	36	26	31	16	21	-33
Net Income / (Loss) Continuing Operations	9.52	1.73	-7.49	-6.18	13	4.48	-1.59	-36	-31	-30	-27
Consolidated Net Income / (Loss)	11	1.73	-7.49	-5.37	14	4.86	-1.59	-31	-30	-30	-27
Net Income / (Loss) Discontinued Operations	1.69	-	-	0.81	0.60	-	-	4.57	0.84	-	-
Depreciation Expense	4.40	4.45	4.55	3.82	1.78	1.86	4.04	4.23	5.13	5.69	5.74
Non-Cash Adjustments To Reconcile Net Income	27	30	29	26	19	21	13	54	41	40	24
Changes in Operating Assets and Liabilities, net	4.42	22	-38	4.31	-10	8.57	9.73	15	-0.27	6.67	-36
Net Cash From Investing Activities	-1.24	23	-0.59	-172	-2.21	0.67	-0.55	-24	-0.68	-2.27	-1.74
Net Cash From Continuing Investing Activities	-1.24	23	-0.59	-172	-2.21	0.67	-0.55	-24	-0.68	-2.27	-1.74
Purchase of Property, Plant & Equipment	-0.28	-0.24	-0.23	-1.79	-2.21	-0.20	-0.05	-0.10	-0.18	-2.67	-1.74
Acquisitions	-2.95	-	-0.40	-170	-	-0.50	-0.50	-	-0.50	-	0.00
Sale and/or Maturity of Investments	1.99	23	2.00	25	-	26	0.00	0.99	3.00	-	-
Net Cash From Financing Activities	-9.36	-51	-16	-16	-8.90	-16	-19	-0.21	-49	-41	-56
Net Cash From Continuing Financing Activities	-9.36	-51	-16	-16	-8.90	-16	-19	-0.21	-49	-41	-56
Repurchase of Common Equity	-10	-50	-16	-15	-10	-15	-20	-	-50	-40	-60
Issuance of Common Equity	2.30	0.16	6.17	0.00	1.65	0.00	5.57	0.00	1.66	0.00	4.59
Other Financing Activities, net	-1.57	-0.89	-6.85	-0.72	-0.55	-0.68	-3.89	-0.22	-0.76	-0.71	-0.58
Effect of Exchange Rate Changes	-1.22	-	-	-0.45	-	-	-	-	-	-	-0.75
Other Net Changes in Cash	2.49	0.07	-0.07	0.81	1.42	0.68	-0.29	4.02	2.60	-	-
Cash Income Taxes Paid	11	11	-0.13	4.91	23	3.51	-29	1.08	0.56	4.16	0.00

This table presents Acxiom's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015	3/31/2014
Total Assets	1,231	1,173	1,334	1,288	1,302	1,473	1,209	1,235	1,150	1,294	1,323
Total Current Assets	602	715	816	826	896	1,192	361	369	376	511	666
Cash & Equivalents	337	464	600	573	718	1,061	140	170	190	141	419
Restricted Cash	2.60	0.00	-	8.90	15	0.00	-	-	-	31	0.00
Short-Term Investments	32	33	7.50	-	-	-	-	-	-	-	-
Accounts Receivable	190	157	148	114	93	79	52	143	139	127	161
Current Deferred & Refundable Income Taxes	8.52	29	30	66	38	7.89	9.98	7.10	9.83	5.24	24
Other Current Assets	32	31	29	64	33	44	20	48	38	35	54
Plant, Property, & Equipment, net	8.18	7.09	12	12	19	26	32	156	183	176	217
Total Noncurrent Assets	621	451	506	451	386	255	817	710	591	606	441
Goodwill	502	363	364	357	298	205	204	593	493	497	358
Intangible Assets	35	9.87	27	40	45	29	14	56	10	9.55	19
Other Noncurrent Operating Assets	85	78	116	53	43	22	38	51	81	99	64
Total Liabilities & Shareholders' Equity	1,231	1,173	1,334	1,288	1,302	1,473	1,209	1,235	1,150	1,294	1,323
Total Liabilities	282	247	271	208	214	142	460	496	451	591	640
Total Current Liabilities	217	175	185	165	161	95	179	230	224	284	249
Accounts Payable	81	87	83	49	57	31	19	40	38	30	36
Accrued Expenses	43	36	46	58	69	41	40	60	48	63	70
Current Deferred Revenue	31	19	16	12	6.58	4.28	4.51	37	44	34	48
Current Employee Benefit Liabilities	62	33	39	46	29	19	14	53	61	37	62
Total Noncurrent Liabilities	66	72	86	42	53	47	282	265	227	307	391
Other Noncurrent Operating Liabilities	66	72	86	42	53	47	10	18	15	6.85	12
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	949	926	1,063	1,081	1,088	1,331	749	739	699	703	683
Total Preferred & Common Equity	949	926	1,063	1,081	1,088	1,331	749	739	699	703	683
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-
Total Common Equity	949	926	1,063	1,081	1,088	1,331	749	739	699	703	683
Common Stock	1,949	1,871	1,736	1,645	1,511	1,421	1,249	1,168	1,095	1,047	995
Retained Earnings	1,314	1,302	1,421	1,455	1,545	1,670	628	603	599	592	603
Treasury Stock	-2,318	-2,252	-2,100	-2,027	-1,974	-1,768	-1,139	-1,039	-1,003	-945	-928
Accumulated Other Comprehensive Income / (Loss)	3.96	4.50	5.73	7.52	5.75	7.80	11	8.00	8.59	9.41	14

This table presents Acxiom's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	12/31/2023	9/30/2023	6/30/2023	12/31/2022	9/30/2022	6/30/2022	12/31/2021
Total Assets	1,253	1,195	1,206	1,225	1,181	1,164	1,166	1,188	1,234	1,343
Total Current Assets	644	582	585	770	728	706	696	705	725	822
Cash & Equivalents	377	339	310	499	492	471	454	486	508	553
Restricted Cash	0.59	2.63	2.62	-	-	-	-	-	-	8.73
Short-Term Investments	7.50	9.49	32	32	32	33	-	-	-	-
Accounts Receivable	211	192	206	199	175	173	173	158	155	157
Current Deferred & Refundable Income Taxes	6.63	4.20	1.93	1.14	0.00	0.00	27	30	29	63
Other Current Assets	42	35	31	38	29	29	42	32	33	41
Plant, Property, & Equipment, net	6.66	7.37	7.70	8.20	5.57	6.06	8.81	11	13	11
Total Noncurrent Assets	603	605	614	447	447	452	461	473	496	510
Goodwill	502	502	502	360	360	363	363	363	363	364
Intangible Assets	23	27	31	4.18	5.36	6.58	13	17	22	32
Other Noncurrent Operating Assets	78	76	81	82	82	82	85	93	111	115
Total Liabilities & Shareholders' Equity	1,253	1,195	1,206	1,225	1,181	1,164	1,166	1,188	1,234	1,343
Total Liabilities	296	263	254	278	259	245	255	228	229	272
Total Current Liabilities	232	199	190	209	187	172	176	150	143	184
Accounts Payable	105	91	85	89	79	74	84	70	67	80
Accrued Expenses	46	45	43	43	37	39	42	41	42	56
Current Deferred Revenue	45	36	38	30	21	27	16	16	15	15
Current Employee Benefit Liabilities	36	27	23	47	35	24	33	23	20	32
Total Noncurrent Liabilities	64	63	65	69	72	73	79	78	85	88
Other Noncurrent Operating Liabilities	64	63	65	69	72	73	79	78	85	88
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	958	932	952	946	922	919	912	960	1,006	1,070
Total Preferred & Common Equity	958	932	952	946	922	919	912	960	1,006	1,070
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	958	932	952	946	922	919	912	960	1,006	1,070
Common Stock	2,038	2,010	1,982	1,925	1,905	1,889	1,826	1,796	1,769	1,704
Retained Earnings	1,320	1,308	1,307	1,320	1,306	1,301	1,334	1,363	1,394	1,450
Treasury Stock	-2,403	-2,392	-2,341	-2,302	-2,292	-2,276	-2,252	-2,201	-2,160	-2,090
Accumulated Other Comprehensive Income / (Loss)	3.49	5.08	3.89	4.51	3.57	4.57	4.18	1.93	3.80	5.89

This table displays calculated financial ratios and metrics derived from Acxiom's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Period end date	3/31/2024	3/31/2023	3/31/2022	3/31/2021	3/31/2020	3/31/2019	3/31/2018	3/31/2017	3/31/2016	3/31/2015	3/31/2014
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	10.57%	12.85%	19.33%	16.41%	33.24%	29.77%	25.94%	-79.44%	5.61%	-0.03%	-24.62%
EBITDA Growth	120.56%	-126.22%	47.06%	38.08%	8.56%	-71.43%	3.59%	-236.51%	55.76%	-22.40%	-72.20%
EBIT Growth	109.07%	-91.95%	45.75%	33.23%	8.69%	-48.40%	-1.61%	-942.04%	62.55%	-1,098.96%	-96.67%
NOPAT Growth	103.80%	-91.95%	45.63%	33.37%	8.69%	-48.40%	-1.61%	-905.99%	60.03%	-2,199.17%	-98.29%
Net Income Growth	110.01%	-250.85%	62.52%	27.50%	-112.11%	4,280.52%	471.57%	-38.71%	160.77%	-225.31%	-84.59%
EPS Growth	109.50%	-258.00%	63.24%	26.09%	-113.42%	4,470.00%	500.00%	-44.44%	164.29%	-216.67%	-84.00%
Operating Cash Flow Growth	206.77%	-55.89%	479.75%	28.05%	-1,344.64%	85.96%	45.57%	-122.78%	85.90%	-36.18%	-35.01%
Free Cash Flow Firm Growth	-136.57%	-2,598.28%	99.00%	-7.69%	-37.52%	-134.25%	336.82%	-1,147.90%	88.91%	-290.42%	-2.80%
Invested Capital Growth	34.70%	-5.84%	-8.74%	40.61%	31.75%	6.14%	-68.19%	14.04%	0.88%	19.80%	-10.94%
Revenue Q/Q Growth	3.65%	1.17%	4.46%	3.14%	7.75%	180.69%	242.03%	-80.14%	2.28%	31.82%	-22.56%
EBITDA Q/Q Growth	340.24%	-32.58%	24.17%	-6.15%	19.11%	-14.67%	57.99%	-199.56%	0.17%	201.66%	-67.18%
EBIT Q/Q Growth	153.17%	-17.96%	26.75%	-10.39%	18.60%	-11.31%	41.27%	-893.84%	22.42%	58.88%	-95.88%
NOPAT Q/Q Growth	-99.07%	-17.96%	26.75%	-10.16%	18.60%	-11.31%	41.27%	-596.36%	19.18%	60.26%	-98.04%
Net Income Q/Q Growth	184.20%	-1.69%	9.27%	-46.66%	24.92%	-4.69%	129.66%	-61.31%	199.91%	67.76%	-82.78%
EPS Q/Q Growth	177.27%	-2.87%	10.71%	-43.16%	4.66%	-1.79%	0.00%	0.00%	0.00%	68.18%	-82.09%
Operating Cash Flow Q/Q Growth	-2.78%	-45.09%	6,166.21%	-610.68%	-385.78%	95.98%	87.88%	-120.16%	13.93%	1,124.82%	-50.63%
Free Cash Flow Firm Q/Q Growth	-136.18%	-155.98%	98.71%	-105.53%	69.83%	-117.36%	376.16%	-136.12%	-116.00%	47.01%	-36.29%
Invested Capital Q/Q Growth	39.09%	-6.39%	-10.48%	26.30%	-1.56%	243.92%	-69.28%	-2.97%	-3.26%	-16.42%	-7.80%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	72.79%	71.49%	72.11%	67.50%	59.88%	57.73%	56.20%	42.79%	42.55%	38.62%	37.21%
EBITDA Margin	3.47%	-18.68%	-9.32%	-21.01%	-39.49%	-57.55%	-43.56%	-56.91%	8.57%	5.81%	7.49%
Operating Margin	1.73%	-21.09%	-12.40%	-27.21%	-47.54%	-69.37%	-60.66%	-75.20%	-1.54%	-4.06%	0.19%
EBIT Margin	1.73%	-21.09%	-12.40%	-27.27%	-47.54%	-69.37%	-60.66%	-75.20%	-1.48%	-4.18%	0.42%
Profit (Net Income) Margin	1.80%	-19.90%	-6.40%	-20.38%	-32.72%	360.11%	10.67%	2.35%	0.79%	-1.37%	1.09%
Tax Burden Percent	34.58%	99.87%	96.46%	74.73%	75.22%	-573.47%	-17.65%	-3.14%	-33.05%	26.68%	-166.09%
Interest Burden Percent	301.31%	94.48%	53.52%	100.00%	91.50%	90.52%	99.62%	99.50%	160.81%	122.78%	-157.22%
Effective Tax Rate	70.63%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.67%	-19.92%	-9.61%	-19.76%	-40.58%	-53.03%	-17.78%	-12.29%	-1.31%	-3.60%	0.18%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.30%	-14.37%	-11.64%	-18.87%	-40.81%	-202.98%	-71.35%	312.21%	-339.75%	-24.39%	-20.80%
Return on Net Nonoperating Assets (RNNOA)	0.60%	7.98%	6.46%	11.44%	30.28%	151.93%	20.93%	12.86%	2.27%	2.01%	1.17%
Return on Equity (ROE)	1.27%	-11.94%	-3.16%	-8.33%	-10.30%	98.90%	3.16%	0.57%	0.96%	-1.59%	1.35%
Cash Return on Invested Capital (CROIC)	-28.90%	-13.91%	-0.48%	-53.52%	-67.98%	-58.98%	85.68%	-25.41%	-2.19%	-21.61%	11.75%
Operating Return on Assets (OROA)	0.95%	-10.04%	-5.00%	-9.33%	-13.04%	-14.77%	-10.93%	-11.02%	-1.03%	-2.57%	0.27%
Return on Assets (ROA)	0.99%	-9.47%	-2.58%	-6.97%	-8.97%	76.69%	1.92%	0.34%	0.55%	-0.84%	0.70%
Return on Common Equity (ROCE)	1.27%	-11.94%	-3.16%	-8.33%	-10.30%	98.90%	3.16%	0.57%	0.96%	-1.59%	1.35%
Return on Equity Simple (ROE_SIMPLE)	1.25%	-12.82%	-3.18%	-8.35%	-11.45%	77.29%	3.13%	0.56%	0.96%	-1.57%	1.29%
Net Operating Profit after Tax (NOPAT)	3.35	-88	-46	-84	-127	-139	-93	-92	-9.14	-23	1.09
NOPAT Margin	0.51%	-14.76%	-8.68%	-19.05%	-33.28%	-48.56%	-42.47%	-52.64%	-1.08%	-2.84%	0.14%
Net Nonoperating Expense Percent (NNEP)	1.96%	-5.55%	2.03%	-0.90%	0.24%	149.96%	53.57%	-324.50%	338.43%	20.80%	20.98%
Cost of Revenue to Revenue	27.21%	28.51%	27.89%	32.50%	40.12%	42.27%	43.80%	57.21%	57.45%	61.38%	62.79%
SG&A Expenses to Revenue	16.70%	21.01%	19.78%	23.52%	28.62%	34.62%	39.93%	55.83%	17.35%	18.99%	14.50%
R&D to Revenue	22.92%	31.71%	29.87%	30.50%	27.85%	30.00%	27.58%	28.25%	8.73%	9.22%	7.80%
Operating Expenses to Revenue	71.06%	92.58%	84.51%	94.71%	107.41%	127.11%	116.87%	117.99%	44.09%	42.68%	37.02%
Earnings before Interest and Taxes (EBIT)	11	-126	-66	-121	-181	-198	-134	-131	-13	-34	3.37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	23	-111	-49	-93	-150	-164	-96	-99	73	47	60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.41	1.53	2.40	3.21	2.04	2.80	2.40	3.00	2.38	2.03	3.85
Price to Tangible Book Value (P/TBV)	5.53	2.57	3.79	5.08	2.98	3.39	3.38	24.45	8.50	7.28	8.59
Price to Revenue (P/Rev)	3.46	2.38	4.82	7.84	5.83	13.03	8.16	12.68	1.96	1.78	3.26
Price to Earnings (P/E)	192.18	0.00	0.00	0.00	0.00	3.62	76.51	539.39	248.61	0.00	296.41
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.52%	0.00%	0.00%	0.00%	0.00%	27.64%	1.31%	0.19%	0.40%	0.00%	0.34%
Enterprise Value to Invested Capital (EV/IC)	3.31	2.15	4.26	5.79	4.18	9.88	7.43	2.85	2.38	2.21	4.36
Enterprise Value to Revenue (EV/Rev)	2.90	1.55	3.67	6.52	3.90	9.31	8.57	13.02	1.96	1.91	3.14
Enterprise Value to EBITDA (EV/EBITDA)	83.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	22.88	32.79	41.91
Enterprise Value to EBIT (EV/EBIT)	167.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	749.36
Enterprise Value to NOPAT (EV/NOPAT)	570.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2,317.72
Enterprise Value to Operating Cash Flow (EV/OCF)	18.09	26.77	24.86	0.00	0.00	0.00	0.00	0.00	14.67	25.09	26.37
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	4.19	0.00	0.00	0.00	34.99
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.31	0.31	0.27	0.39	0.47
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.30	0.26	0.23	0.35	0.42
Financial Leverage	-0.46	-0.56	-0.55	-0.61	-0.74	-0.75	-0.29	0.04	-0.01	-0.08	-0.06
Leverage Ratio	1.28	1.26	1.22	1.19	1.15	1.29	1.64	1.66	1.74	1.89	1.93
Compound Leverage Factor	3.86	1.19	0.65	1.19	1.05	1.17	1.64	1.65	2.80	2.32	-3.03
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	23.45%	23.66%	21.39%	28.26%	31.75%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.16%	4.11%	3.63%	3.29%	2.86%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	23.28%	19.55%	17.76%	24.97%	28.89%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	76.55%	76.34%	78.61%	71.74%	68.25%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-2.39	-2.30	2.61	5.92	5.27
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-0.93	-0.59	0.01	2.24	-1.68
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-2.38	-1.90	2.17	5.23	4.80
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-2.45	-2.49	-20.79	-12.11	291.41
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.96	-0.64	-0.06	-4.59	-92.65
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-2.44	-2.06	-17.27	-10.70	265.20
Altman Z-Score	7.29	5.71	7.94	12.26	8.38	17.95	3.07	3.29	3.81	2.84	4.09
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.03%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.78	4.09	4.42	5.00	5.55	12.53	2.02	1.60	1.68	1.80	2.67
Quick Ratio	2.58	3.74	4.10	4.16	5.02	11.99	1.08	1.36	1.47	0.94	2.32
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-145	-61	-2.28	-228	-212	-154	450	-190	-15	-137	72
Operating Cash Flow to CapEx	2,483.10%	733.41%	1,735.43%	-942.25%	-263.66%	-22.89%	-163.06%	0.00%	177.97%	78.97%	164.54%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.99	-17.92	8.33
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	14.82	7.97	11.05
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.49	-2.12	4.33
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.55	0.48	0.40	0.34	0.27	0.21	0.18	0.15	0.70	0.62	0.64
Accounts Receivable Turnover	3.79	3.90	4.03	4.28	4.44	4.37	2.26	1.24	6.40	5.60	5.02
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	86.42	64.09	45.02	28.33	16.78	9.78	2.34	1.03	4.73	4.09	3.60
Accounts Payable Turnover	2.14	2.00	2.23	2.72	3.46	4.83	3.27	2.57	14.40	14.91	14.05
Days Sales Outstanding (DSO)	96.19	93.52	90.66	85.29	82.16	83.45	161.53	293.88	57.01	65.21	72.67
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	170.58	182.16	163.47	134.18	105.44	75.53	111.64	142.25	25.34	24.48	25.98
Cash Conversion Cycle (CCC)	-74.39	-88.63	-72.80	-48.89	-23.28	7.92	49.90	151.63	31.67	40.73	46.69
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	578	429	455	499	355	269	254	798	699	693	579
Invested Capital Turnover	1.31	1.35	1.11	1.04	1.22	1.09	0.42	0.23	1.22	1.27	1.31
Increase / (Decrease) in Invested Capital	149	-27	-44	144	86	16	-544	98	6.10	115	-71
Enterprise Value (EV)	1,912	922	1,941	2,890	1,485	2,660	1,886	2,275	1,667	1,534	2,526
Market Capitalization	2,283	1,419	2,549	3,472	2,218	3,722	1,796	2,216	1,666	1,429	2,627
Book Value per Share	$14.34	$14.31	$15.59	$16.15	$16.14	$19.51	$9.47	$9.49	$8.99	$9.10	$8.94
Tangible Book Value per Share	$6.24	$8.55	$9.87	$10.21	$11.05	$16.09	$6.72	$1.16	$2.52	$2.54	$4.00
Total Capital	949	926	1,063	1,081	1,088	1,331	979	968	889	980	1,000
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	229	229	190	277	318
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	228	189	158	245	289
Net Debt	-372	-497	-608	-582	-733	-1,061	89	59	0.51	105	-101
Capital Expenditures (CapEx)	4.26	4.70	4.50	2.18	11	8.64	8.64	-14	64	77	58
Debt-free, Cash-free Net Working Capital (DFCFNWC)	14	42	24	79	2.39	35	44	7.78	-5.38	88	26
Debt-free Net Working Capital (DFNWC)	385	540	631	660	735	1,097	184	178	184	260	445
Net Working Capital (NWC)	385	540	631	660	735	1,097	182	138	152	228	416
Net Nonoperating Expense (NNE)	-8.53	31	-12	5.88	-2.13	-1,167	-117	-96	-16	-12	-7.71
Net Nonoperating Obligations (NNO)	-372	-497	-608	-582	-733	-1,061	-495	59	0.51	-9.88	-104
Total Depreciation and Amortization (D&A)	12	14	16	28	31	34	38	32	85	80	57
Debt-free, Cash-free Net Working Capital to Revenue	2.11%	7.12%	4.47%	17.78%	0.63%	12.42%	19.79%	4.45%	-0.63%	10.91%	3.23%
Debt-free Net Working Capital to Revenue	58.43%	90.47%	119.41%	149.08%	193.13%	384.06%	83.40%	101.93%	21.67%	32.28%	55.22%
Net Working Capital to Revenue	58.43%	90.47%	119.41%	149.08%	193.13%	384.06%	82.68%	79.14%	17.88%	28.28%	51.67%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.18	($1.79)	($0.50)	($1.36)	($1.84)	$13.71	$0.30	$0.05	$0.09	($0.14)	$0.12
Adjusted Weighted Average Basic Shares Outstanding	66.15M	66.40M	68.41M	68.41M	65.34M	68.97M	77.06M	78.51M	77.52M	78.17M	76.96M
Adjusted Diluted Earnings per Share	$0.17	($1.79)	($0.50)	($1.36)	($1.84)	$13.71	$0.29	$0.05	$0.09	($0.14)	$0.12
Adjusted Weighted Average Diluted Shares Outstanding	66.15M	66.40M	68.41M	68.41M	65.34M	68.97M	77.06M	78.51M	77.52M	78.17M	76.96M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	66.15M	66.40M	68.41M	68.41M	65.34M	68.97M	77.06M	78.51M	77.52M	78.17M	76.96M
Normalized Net Operating Profit after Tax (NOPAT)	7.98	-88	-46	-84	-127	-139	-93	-92	-4.36	-23	19
Normalized NOPAT Margin	1.21%	-14.76%	-8.68%	-19.05%	-33.28%	-48.56%	-42.47%	-52.64%	-0.51%	-2.84%	2.30%
Pre Tax Income Margin	5.21%	-19.92%	-6.63%	-27.27%	-43.50%	-62.80%	-60.44%	-74.82%	-2.39%	-5.14%	-0.66%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.64	-4.39	0.39
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-1.19	-2.98	0.13
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-9.97	-14.48	-6.32
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-9.52	-13.07	-6.59
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.82%
Augmented Payout Ratio	509.23%	-126.36%	-173.27%	-46.87%	-146.32%	7.24%	378.55%	743.48%	787.17%	-89.46%	605.06%

This table displays calculated financial ratios and metrics derived from Acxiom's official financial filings.

Metric	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022	6/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.39%	16.02%	14.21%	15.63%	9.62%	8.68%	8.31%	4.87%	12.81%	15.56%	19.49%
EBITDA Growth	12.31%	18.52%	-67.99%	75.64%	190.25%	147.54%	133.37%	-95.43%	-129.49%	-801.87%	-33.08%
EBIT Growth	-3.47%	-8.78%	-331.19%	69.71%	163.47%	130.54%	109.12%	-68.50%	-70.74%	-334.71%	-41.49%
NOPAT Growth	-19.91%	-55.78%	-626.41%	69.71%	155.63%	112.31%	97.18%	-68.50%	-73.72%	-371.08%	23.77%
Net Income Growth	-19.80%	-64.38%	-372.19%	82.87%	147.09%	115.98%	94.17%	-6.71%	-93.07%	-373.27%	-256.74%
EPS Growth	-19.05%	-57.14%	-450.00%	81.25%	145.65%	115.56%	95.00%	-11.63%	-100.00%	-400.00%	-260.00%
Operating Cash Flow Growth	172.51%	55.45%	-136.31%	-9.85%	4.98%	67.32%	177.00%	-47.98%	-38.09%	96.08%	-93.54%
Free Cash Flow Firm Growth	-387.87%	-329.91%	-337.52%	-2,376.50%	53.95%	134.53%	433.68%	-126.69%	127.47%	122.88%	109.60%
Invested Capital Growth	37.94%	46.06%	46.27%	34.70%	-9.35%	-16.17%	-16.65%	-5.84%	-9.95%	-10.25%	-6.28%
Revenue Q/Q Growth	5.35%	5.41%	2.39%	-1.16%	8.76%	3.77%	3.66%	-6.30%	7.83%	3.41%	0.37%
EBITDA Q/Q Growth	59.78%	483.15%	119.58%	-161.54%	68.62%	57.50%	114.91%	-127.98%	11.17%	-10.56%	12.71%
EBIT Q/Q Growth	95.98%	242.66%	63.24%	-193.91%	85.20%	261.59%	104.82%	-96.78%	10.88%	-7.91%	10.96%
NOPAT Q/Q Growth	572.98%	130.21%	63.24%	-207.15%	271.59%	596.26%	98.47%	-96.78%	17.76%	-13.75%	8.46%
Net Income Q/Q Growth	547.23%	123.13%	-39.38%	-138.44%	187.42%	406.62%	94.94%	-5.66%	2.47%	-11.82%	7.40%
EPS Q/Q Growth	466.67%	127.27%	-22.22%	-142.86%	200.00%	450.00%	95.83%	-4.35%	-2.22%	-12.50%	6.98%
Operating Cash Flow Q/Q Growth	-18.85%	696.01%	-133.74%	66.97%	-53.71%	39.20%	-16.21%	94.45%	-26.22%	164.06%	-156.61%
Free Cash Flow Firm Q/Q Growth	17.58%	6.87%	-23.15%	-404.55%	-34.17%	-3.79%	1,383.99%	-118.93%	0.28%	118.93%	-35.78%
Invested Capital Q/Q Growth	-1.40%	-4.21%	5.01%	39.09%	4.40%	-4.07%	-3.30%	-6.39%	-3.45%	-4.63%	9.24%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	71.86%	72.38%	70.59%	72.23%	74.16%	74.22%	70.39%	70.75%	72.71%	71.24%	71.16%
EBITDA Margin	9.76%	6.44%	1.16%	-6.08%	9.77%	6.30%	4.15%	-28.87%	-11.86%	-14.40%	-13.47%
Operating Margin	7.51%	4.04%	-2.98%	-8.31%	8.74%	5.13%	1.47%	-31.71%	-15.10%	-19.80%	-18.00%
EBIT Margin	7.51%	4.04%	-2.98%	-8.31%	8.74%	5.13%	1.47%	-31.71%	-15.10%	-18.27%	-17.51%
Profit (Net Income) Margin	5.74%	0.93%	-4.26%	-3.13%	8.04%	3.04%	-1.03%	-21.10%	-18.71%	-20.69%	-19.13%
Tax Burden Percent	59.93%	14.82%	931.47%	58.37%	64.09%	33.22%	-22.28%	73.99%	120.25%	113.25%	109.30%
Interest Burden Percent	127.49%	156.06%	15.32%	64.48%	143.46%	178.35%	313.61%	89.95%	103.07%	100.00%	100.00%
Effective Tax Rate	49.10%	85.18%	0.00%	0.00%	38.65%	69.42%	122.28%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	5.64%	0.86%	-2.79%	-7.62%	7.82%	2.24%	-0.44%	-29.95%	-12.89%	-15.80%	-13.52%
ROIC Less NNEP Spread (ROIC-NNEP)	4.82%	0.72%	-1.89%	-8.69%	6.87%	1.77%	-0.22%	-30.25%	-10.35%	-13.84%	-11.77%
Return on Net Nonoperating Assets (RNNOA)	-2.32%	-0.34%	0.86%	4.02%	-3.64%	-0.95%	0.12%	16.80%	5.30%	7.01%	5.97%
Return on Equity (ROE)	3.32%	0.52%	-1.93%	-3.60%	4.17%	1.29%	-0.32%	-13.15%	-7.59%	-8.78%	-7.56%
Cash Return on Invested Capital (CROIC)	-31.95%	-37.40%	-37.46%	-28.90%	92.07%	7.86%	3.13%	-13.91%	-4.97%	-2.67%	-3.53%
Operating Return on Assets (OROA)	4.42%	2.40%	-1.72%	-4.56%	4.65%	2.69%	0.75%	-15.09%	-7.10%	-8.45%	-7.78%
Return on Assets (ROA)	3.37%	0.56%	-2.45%	-1.72%	4.28%	1.60%	-0.52%	-10.05%	-8.80%	-9.57%	-8.50%
Return on Common Equity (ROCE)	3.32%	0.52%	-1.93%	-3.60%	4.17%	1.29%	-0.32%	-13.15%	-7.59%	-8.78%	-7.56%
Return on Equity Simple (ROE_SIMPLE)	0.01%	0.31%	0.63%	0.00%	-1.49%	-6.27%	-10.13%	0.00%	-12.80%	-10.67%	-7.80%
Net Operating Profit after Tax (NOPAT)	7.47	1.11	-3.67	-9.99	9.33	2.51	-0.51	-33	-17	-20	-18
NOPAT Margin	3.82%	0.60%	-2.09%	-5.81%	5.36%	1.57%	-0.33%	-22.20%	-10.57%	-13.86%	-12.60%
Net Nonoperating Expense Percent (NNEP)	0.82%	0.14%	-0.90%	1.06%	0.94%	0.47%	-0.21%	0.29%	-2.55%	-1.95%	-1.76%
Return On Investment Capital (ROIC_SIMPLE)	0.78%	-	-	-	0.99%	-	-	-	-	-	-
Cost of Revenue to Revenue	28.14%	27.62%	29.41%	27.77%	25.84%	25.78%	29.61%	29.25%	27.29%	28.76%	28.84%
SG&A Expenses to Revenue	16.37%	16.91%	17.60%	17.60%	15.67%	16.27%	17.31%	22.09%	23.11%	19.52%	19.08%
R&D to Revenue	21.87%	23.66%	25.07%	26.28%	21.73%	21.10%	22.40%	35.14%	27.22%	31.37%	33.51%
Operating Expenses to Revenue	64.35%	68.34%	73.57%	80.54%	65.41%	69.09%	68.92%	102.46%	87.81%	91.04%	89.16%
Earnings before Interest and Taxes (EBIT)	15	7.49	-5.25	-14	15	8.21	2.27	-47	-24	-27	-25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	19	12	2.05	-10	17	10	6.40	-43	-19	-21	-19
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.07	1.77	2.15	2.41	2.62	2.07	2.06	1.53	1.71	1.27	1.75
Price to Tangible Book Value (P/TBV)	4.58	4.09	4.88	5.53	4.26	3.43	3.46	2.57	2.91	2.10	2.83
Price to Revenue (P/Rev)	2.72	2.33	3.00	3.46	3.90	3.07	3.12	2.38	2.64	2.13	3.19
Price to Earnings (P/E)	24,775.96	579.78	342.39	192.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.17%	0.29%	0.52%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	2.79	2.24	2.81	3.31	4.70	3.48	3.36	2.15	2.41	1.55	2.52
Enterprise Value to Revenue (EV/Rev)	2.19	1.84	2.50	2.90	3.06	2.23	2.29	1.55	1.87	1.28	2.27
Enterprise Value to EBITDA (EV/EBITDA)	80.41	73.12	106.95	83.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	605.69	410.61	437.84	167.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	6,677.45	2,764.01	570.85	5.43	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	13.42	14.37	24.09	18.09	17.95	12.84	14.89	26.77	17.61	10.13	20.20
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	4.85	40.40	97.49	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.48	-0.47	-0.45	-0.46	-0.53	-0.54	-0.53	-0.56	-0.51	-0.51	-0.51
Leverage Ratio	1.30	1.28	1.27	1.28	1.29	1.26	1.25	1.26	1.27	1.22	1.19
Compound Leverage Factor	1.66	2.00	0.19	0.83	1.85	2.25	3.91	1.13	1.30	1.22	1.19
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	6.51	6.30	7.29	7.22	7.97	7.08	7.28	5.94	6.24	5.78	7.15
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.78	2.92	3.09	2.78	3.69	3.90	4.10	4.09	3.96	4.69	5.07
Quick Ratio	2.57	2.71	2.90	2.58	3.50	3.74	3.93	3.74	3.57	4.28	4.63
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-150	-182	-196	-159	52	79	82	-6.41	34	34	15
Operating Cash Flow to CapEx	15,998.94%	23,068.88%	-4,127.43%	1,543.44%	748.80%	17,882.00%	48,477.36%	29,771.84%	8,810.06%	799.66%	-1,916.66%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.59	0.60	0.58	0.55	0.53	0.52	0.51	0.48	0.47	0.46	0.44
Accounts Receivable Turnover	3.56	3.86	3.59	3.79	3.41	3.74	3.71	3.90	3.57	3.96	4.01
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	98.07	109.23	99.13	86.42	74.83	74.77	63.71	64.09	60.81	53.58	46.64
Accounts Payable Turnover	2.12	2.29	2.34	2.14	2.03	2.32	2.48	2.00	2.02	2.62	2.86
Days Sales Outstanding (DSO)	102.67	94.65	101.59	96.19	106.90	97.66	98.29	93.52	102.20	92.15	90.95
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	172.23	159.33	156.18	170.58	179.89	157.34	147.19	182.16	180.56	139.47	127.61
Cash Conversion Cycle (CCC)	-69.56	-64.68	-54.59	-74.39	-72.99	-59.67	-48.90	-88.63	-78.36	-47.32	-36.66
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	573	581	607	578	415	398	415	429	458	474	497
Invested Capital Turnover	1.47	1.45	1.33	1.31	1.46	1.42	1.33	1.35	1.22	1.14	1.07
Increase / (Decrease) in Invested Capital	158	183	192	149	-43	-77	-83	-27	-51	-54	-33
Enterprise Value (EV)	1,597	1,300	1,701	1,912	1,950	1,385	1,393	922	1,105	734	1,251
Market Capitalization	1,982	1,651	2,047	2,283	2,482	1,909	1,896	1,419	1,558	1,219	1,759
Book Value per Share	$14.67	$13.99	$14.39	$14.34	$14.45	$13.93	$13.83	$14.31	$13.71	$14.30	$14.98
Tangible Book Value per Share	$6.63	$6.05	$6.34	$6.24	$8.89	$8.41	$8.26	$8.55	$8.05	$8.64	$9.24
Total Capital	958	932	952	949	946	922	919	926	912	960	1,006
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-385	-351	-345	-372	-531	-524	-504	-497	-454	-486	-508
Capital Expenditures (CapEx)	0.28	0.24	0.23	1.79	2.21	0.20	0.05	0.10	0.18	2.67	1.74
Debt-free, Cash-free Net Working Capital (DFCFNWC)	27	32	50	14	30	17	30	42	67	69	74
Debt-free Net Working Capital (DFNWC)	412	383	395	385	561	541	534	540	520	555	582
Net Working Capital (NWC)	412	383	395	385	561	541	534	540	520	555	582
Net Nonoperating Expense (NNE)	-3.74	-0.62	3.82	-4.62	-4.65	-2.35	1.08	-1.62	13	10	9.30
Net Nonoperating Obligations (NNO)	-385	-351	-345	-372	-531	-524	-504	-497	-454	-486	-508
Total Depreciation and Amortization (D&A)	4.40	4.45	7.30	3.82	1.78	1.86	4.13	4.23	5.13	5.69	5.74
Debt-free, Cash-free Net Working Capital to Revenue	3.75%	4.47%	7.34%	2.11%	4.67%	2.75%	4.90%	7.12%	11.35%	12.07%	13.33%
Debt-free Net Working Capital to Revenue	56.56%	54.11%	58.01%	58.43%	88.13%	87.12%	87.72%	90.47%	88.25%	97.01%	105.43%
Net Working Capital to Revenue	56.56%	54.11%	58.01%	58.43%	88.13%	87.12%	87.72%	90.47%	88.25%	97.01%	105.43%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.17	$0.03	($0.11)	($0.08)	$0.21	$0.07	($0.02)	($0.48)	($0.46)	($0.45)	($0.40)
Adjusted Weighted Average Basic Shares Outstanding	65.76M	65.26M	66.61M	66.15M	66.18M	65.51M	66.19M	66.40M	64.71M	66.48M	67.14M
Adjusted Diluted Earnings per Share	$0.17	$0.03	($0.11)	($0.09)	$0.21	$0.07	($0.02)	($0.48)	($0.46)	($0.45)	($0.40)
Adjusted Weighted Average Diluted Shares Outstanding	65.76M	65.26M	66.61M	66.15M	66.18M	65.51M	66.19M	66.40M	64.71M	66.48M	67.14M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	65.76M	65.26M	66.61M	66.15M	66.18M	65.51M	66.19M	66.40M	64.71M	66.48M	67.14M
Normalized Net Operating Profit after Tax (NOPAT)	7.47	5.24	-3.67	-9.99	9.33	5.75	1.59	-33	-17	-20	-18
Normalized NOPAT Margin	3.82%	2.83%	-2.09%	-5.81%	5.36%	3.59%	1.03%	-22.20%	-10.57%	-13.86%	-12.60%
Pre Tax Income Margin	9.57%	6.30%	-0.46%	-5.36%	12.54%	9.16%	4.62%	-28.52%	-15.56%	-18.27%	-17.51%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	113,660.00%	3,190.38%	938.17%	509.23%	-321.23%	-147.53%	-118.35%	-126.36%	-136.55%	-111.93%	-114.26%

Frequently Asked Questions About Acxiom's Financials

When does Acxiom's fiscal year end?

According to the most recent income statement we have on file, Acxiom's financial year ends in March. Their financial year 2024 ended on March 31, 2024.

How has Acxiom's net income changed over the last 10 years?

Acxiom's net income appears to be on a downward trend, with a most recent value of $11.88 million in 2024, rising from $8.80 million in 2014. The previous period was -$118.70 million in 2023.

What is Acxiom's operating income?

Acxiom's total operating income in 2024 was $11.40 million, based on the following breakdown:

Total Gross Profit: $480.17 million
Total Operating Expenses: $468.77 million

How has Acxiom revenue changed over the last 10 years?

Over the last 10 years, Acxiom's total revenue changed from $805.15 million in 2014 to $659.66 million in 2024, a change of -18.1%.

How much debt does Acxiom have?

Acxiom's total liabilities were at $282.31 million at the end of 2024, a 14.5% increase from 2023, and a 55.9% decrease since 2014.

How much cash does Acxiom have?

In the past 10 years, Acxiom's cash and equivalents has ranged from $140.02 million in 2018 to $1.06 billion in 2019, and is currently $336.87 million as of their latest financial filing in 2024.

How has Acxiom's book value per share changed over the last 10 years?

Over the last 10 years, Acxiom's book value per share changed from 8.94 in 2014 to 14.34 in 2024, a change of 60.4%.

Related Companies

This page (NASDAQ:ACXM) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Acxiom (ACXM) Financials

Frequently Asked Questions About Acxiom's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Acxiom (ACXM) Financials

Annual Income Statements for Acxiom

Quarterly Income Statements for Acxiom

Annual Cash Flow Statements for Acxiom

Quarterly Cash Flow Statements for Acxiom

Annual Balance Sheets for Acxiom

Quarterly Balance Sheets for Acxiom

Annual Metrics And Ratios for Acxiom

Quarterly Metrics And Ratios for Acxiom

Frequently Asked Questions About Acxiom's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools